Dayvigo Must Be Taken Daily to Be Effective
Dayvigo (lemborexant) should be taken daily, not as needed (PRN), for effective treatment of insomnia. The FDA-approved dosing explicitly states that lemborexant is taken "no more than once per night, immediately before going to bed" as part of regular nightly therapy 1.
Why Daily Dosing Is Required
The mechanism of action and clinical trial design support daily administration:
Sustained efficacy requires consistent use: Clinical trials demonstrating lemborexant's effectiveness involved nightly administration over extended periods (1 month to 12 months) 2. The significant improvements in sleep onset latency, wake after sleep onset, and sleep efficiency were achieved through continuous daily dosing 3, 4.
Therapeutic benefits build over time: While some improvement occurs early, the full therapeutic effect on daytime functioning (measured by Insomnia Severity Index and Fatigue Severity Scale) was maintained and optimized with continued daily use over 6 months 5. This suggests that intermittent PRN dosing would not provide the same sustained benefit.
No evidence supports PRN dosing: The FDA label and all pivotal trials used daily dosing schedules 1. There are no data supporting intermittent or as-needed administration 6.
Dosing Specifics
- Standard dose: 5 mg nightly, with option to increase to 10 mg based on clinical response 1
- Timing: Take immediately before bed with at least 7 hours remaining for sleep
- Food interaction: Avoid taking with or soon after meals, as this delays sleep onset 1
Important Caveats
Do not confuse this with older sleep medications: Unlike some benzodiazepines or Z-drugs that were sometimes used PRN, dual orexin receptor antagonists like lemborexant work through sustained modulation of the sleep-wake system and require regular nightly dosing to maintain efficacy 4.
Long-term safety profile supports daily use: Studies up to 12 months showed no evidence of tolerance, withdrawal symptoms, or rebound insomnia with continuous daily use, making it appropriate for chronic nightly administration 2.
The most common side effect with daily use is somnolence (7-10% vs 1% placebo), which typically occurs early in treatment 1, 3. This risk is manageable with proper patient counseling about avoiding activities requiring alertness if daytime somnolence occurs.